Breast Cancer Foundation NZ
Synthetic target of lobular breast cancer
February 2014
Research Grant
What is the problem and who is affected?
For a cancer to occur and develop, tumour suppressor genes must be inactivated. If it was possible to prevent this from happening, then cancer tumours wouldn't be able to grow. Unfortunately, when this happens the tumour suppressor protein is lost from the cell, so it can't be targeted by conventional therapy.
What is this research hoping to achieve?
Guilford and his team are convinced that the loss of tumour suppressor gene CDH1, creates vulnerabilities in the cancer cell that can be targeted by drugs. They aim to study these vulnerabilities and develop new breast cancer treatments which are able to target them.
-
AprilResearch Grant
Targeting immune response in ER+ breast cancer patients
-
FebruaryResearch Grant
Synthetic target of lobular breast cancer
-
FebruaryResearch Grant
A hormone inhibitor that reduces risk of developing breast cancer
-
FebruaryResearch Grant
The role of fatty tissue in the spread of breast cancer
-
FebruaryMedical Equipment
L-Dex Machines